Literature DB >> 9155210

Folate, vitamin B12, and neuropsychiatric disorders.

T Bottiglieri1.   

Abstract

Folate and vitamin B12 are required both in the methylation of homocysteine to methionine and in the synthesis of S-adenosylmethionine. S-adenosylmethionine is involved in numerous methylation reactions involving proteins, phospholipids, DNA, and neurotransmitter metabolism. Both folate and vitamin B12 deficiency may cause similar neurologic and psychiatric disturbances including depression, dementia, and a demyelinating myelopathy. A current theory proposes that a defect in methylation processes is central to the biochemical basis of the neuropsychiatry of these vitamin deficiencies. Folate deficiency may specifically affect central monoamine metabolism and aggravate depressive disorders. In addition, the neurotoxic effects of homocysteine may also play a role in the neurologic and psychiatric disturbances that are associated with folate and vitamin B12 deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9155210     DOI: 10.1111/j.1753-4887.1996.tb03851.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  40 in total

Review 1.  [Folic acid and vitamin B12 determination in the assessment of cognitive disorders : Overview and data analysis from a university outpatient memory clinic].

Authors:  Robert Haußmann; Cathrin Sauer; Stefanie Neumann; Anne Zweiniger; Jan Lange; Markus Donix
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

Review 2.  Nutrition and depression: implications for improving mental health among childbearing-aged women.

Authors:  Lisa M Bodnar; Katherine L Wisner
Journal:  Biol Psychiatry       Date:  2005-07-25       Impact factor: 13.382

3.  Associations of the Ratios of n-3 to n-6 Dietary Fatty Acids With Longitudinal Changes in Depressive Symptoms Among US Women.

Authors:  May A Beydoun; Marie T Fanelli Kuczmarski; Hind A Beydoun; Ola S Rostant; Michele K Evans; Alan B Zonderman
Journal:  Am J Epidemiol       Date:  2015-04-07       Impact factor: 4.897

4.  S-alkylated homocysteine derivatives: new inhibitors of human betaine-homocysteine S-methyltransferase.

Authors:  Jiri Jiracek; Michaela Collinsova; Ivan Rosenberg; Milos Budesinsky; Eva Protivinska; Hana Netusilova; Timothy A Garrow
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

5.  ω-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women.

Authors:  May A Beydoun; Marie T Fanelli Kuczmarski; Hind A Beydoun; Joseph R Hibbeln; Michele K Evans; Alan B Zonderman
Journal:  J Nutr       Date:  2013-09-04       Impact factor: 4.798

6.  Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults.

Authors:  May A Beydoun; Monal R Shroff; Hind A Beydoun; Alan B Zonderman
Journal:  Psychosom Med       Date:  2010-09-14       Impact factor: 4.312

7.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

8.  Megaloblastic anemia with hypotension and transient delirium as the primary symptoms: report of a case.

Authors:  Qin Zhang; Xue-Ying Lv; Yun-Mei Yang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting.

Authors:  M C Smith Fawzi; S F Kaaya; J Mbwambo; G I Msamanga; G Antelman; R Wei; D J Hunter; W W Fawzi
Journal:  HIV Med       Date:  2007-05       Impact factor: 3.180

10.  A cross-sectional study of general cognitive abilities among Uruguayan school children with low-level arsenic exposure, potential effect modification by methylation capacity and dietary folate.

Authors:  Gauri Desai; Gabriel Barg; Elena I Queirolo; Marie Vahter; Fabiana Peregalli; Nelly Mañay; Katarzyna Kordas
Journal:  Environ Res       Date:  2018-02-24       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.